RSS RSS Twitter Twitter
macnn

02/06/2008, 11:35am, EST

Wednesday, February 6th

Fusion DMC manages bio-pharma documents

A company called Tourtellotte Solutions has released Fusion DMC, a multi-platform document management system. The technology is specifically aimed at the bio-pharmaceutical industry, and lets users author, review and approve documents in a collaborative process. Both regulated and non-regulated documents can be processed, and users interact with a single, unified graphical interface for all of the program's different components. The dashboard can be viewed locally and remotely.

The software has further been coded with hooks for a number of third-party programs, such as PleaseTech's PleaseReview, the QUMAS Compliance Suite and EMC Documentum. Fusion operates on Mac, Windows and Linux systems; companies must talk to Tourtellotte regarding pricing.


Filed under: software, enterprise

, , comment, del.icio.us, slashdot, digg, buzz , Twitter



post a comment
Reader Reactions (Please use <i></i> for italic text)

subscribe to comments
for this article




Expand All   Global Settings
Be the first to post comments on this story.
Your Comments

In order to post comments: If you are a registered member, please login with your MacNN Forums username and password otherwise please uncheck the checkbox below.


Registered Member?
macnn forums login:

macnn forums password:

Not a member of the MacNN forums? Register now for free.

RSS Feeds

Have the latest content delivered to your desktop via RSS. Use the links below to get access to a specific blog, news, or reviews feed.



  MacNN -all

  MacNN Reviews

  MacNN Podcasts

  iPodNN

  Electronista

  Left Lane News
Want To Sell Your Laptop? Any Condition - receive Top Cash. Get an instant quote. Free shipping www.CashForLaptops.com

Internet Marketing School - 100% Online: Master SEO, SEM, E Commerce, Media & More with a U of San Francisco Certificate.

Buy from The Apple Store, iTunes.com, Amazon.com, TechDepot, OfficeDepot, Computers4Sure, or donate.